GTBPVSNIVF• 3 Months (Normalized)
GTBP vs NIVF (GT Biopharma Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Jun 27 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+1513.64%
GT Biopharma Inc.
Normalized Baseline0.00%
NIVF Performance $0.59
-87.37%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1601.01 pts
GTBP outperforming by 1601.01 percentage points
GTBPNIVF
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | GTBP Price | GTBP Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $7.10 | +1513.64% | $0.59 | -87.37% | +1601.01% |
| Sep 22, 2026 | $- | $0.73 | -84.29% | - | |
| Sep 21, 2026 | $7.18 | +1531.82% | $0.72 | -84.59% | +1616.41% |
| Sep 18, 2026 | $7.16 | +1527.27% | $0.72 | -84.61% | +1611.88% |
| Sep 17, 2026 | $7.49 | +1602.27% | $0.72 | -84.69% | +1686.96% |
| Sep 16, 2026 | $7.81 | +1675.00% | $0.79 | -83.19% | +1758.19% |
| Sep 15, 2026 | $9.00 | +1945.45% | $0.84 | -82.02% | +2027.47% |
| Sep 14, 2026 | $11.63 | +2543.18% | $0.93 | -80.11% | +2623.29% |
| Sep 11, 2026 | $8.61 | +1856.82% | $1.06 | -77.31% | +1934.13% |
| Sep 10, 2026 | $6.18 | +1304.55% | $1.11 | -76.24% | +1380.79% |
| Sep 09, 2026 | $5.98 | +1259.09% | $1.10 | -76.45% | +1335.54% |
| Sep 08, 2026 | $- | $1.11 | -76.24% | - | |
| Sep 04, 2026 | $0.24 | -45.23% | $1.14 | -75.59% | +30.36% |
| Sep 03, 2026 | $0.25 | -42.73% | $1.18 | -74.74% | +32.01% |
| Sep 02, 2026 | $0.28 | -35.68% | $1.21 | -74.10% | +38.42% |
Page 1 of 5